PPARGC1A and metabolic dysfunction-associated steatotic liver disease: The TET2 p.Ile1762Val variant has also previously been reported to correlate with liver PPARƴ coactivator 1 alpha (PGC1A)-methylation levels and non-alcoholic fatty liver disease [27].